J&J submitted a New Drug Application to the FDA for TAR-200 in January 2025 following positive data from the SunRISe-1 trial.

Zenflow has reported that its Spring System demonstrated durable benefits three years post-placement for individuals with BPH ...

Abbott has reported new data from its Volt CE Mark Study in individuals treated with PFA therapy using the Volt PFA System ...

A new paper evaluating Neuromod’s tinnitus treatment has found that 91.5% of patients saw reductions after 12 weeks of ...

Kardium has revealed positive one-year efficacy results on its pulsed field ablation (PFA) device, the Globe PF System.

The US FDA has granted approval for Medtronic’s OmniaSecure defibrillation lead intended for insertion in the right ...